Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 trial of MHAA4549A plus oseltamivir versus oseltamivir in severe influenza A infection
2014-000461-43Phase 2Terminated
- Sponsor
- Genentech
- Start
- Oct 2014
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Influenza A infection comparing MHAA4549A + oseltamivir with Placebo + oseltamivir (2 arms). Primary endpoint: Time to normalization of respiratory function. Started Oct 2014; status: terminated.
02
Drugs
vedolizumab
03
Conditions
Influenza A infection
Beyond the preview
Go deeper on 2014-000461-43.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-000461-43.